Tag: Pneumonia

LEAP 2: Lefamulin vs Moxifloxacin for CAP

by Salim Rezaie posted December 2, 2019 No Comments

Background: Recently there have been some observed trends in decreasing susceptibility among Strep pneumoniae isolates to antimicrobials used to treat community acquired pneumonia (CAP) (Resistance to oral penicillin and macrolides for Strep pneumoniae & macrolides and fluoroquinolones for Staph aureus). ...

Infectious Disease

Update in Community Acquired Pneumonia (CAP) Treatment: Macrolide Resistance

by Anand Swaminathan posted July 6, 2018 No Comments

Background: Community acquired pneumonia (CAP), defined as lower bronchial tree infection in a patient that has not been hospitalized in the last 90 days is a commonly diagnosed disease. There are between 2-4 million episodes per year in the US with roughly ...

Infectious Disease